Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
Mitsubishi UFJ Capital
TokyoPre-Seed–Late Stage$952K – $269M
CIBC
ChicagoPre-Seed–Late Stage$1.5M – $29.2M
Ameba Capital
ShanghaiSeed–Late Stage
3 people
Braxton Capital Ventures Pte Ltd.
SingaporeSeed–Late Stage
3 people
Capricornio Capital
Growth–Late Stage$1M – $10M
Cdh Venture Management Company Limited
Hong KongSeed–Late Stage$7.1M – $300M
Company K Partners
SeoulSeed–Late Stage$2.2M – $44M
Coolidge Corner Investment
SeoulSeed–Late Stage$223K – $11M
IDO Investments
MuscatSeries A–Late Stage$2.3M – $140M
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
West Virginia Jobs Investment Trust
CharlestonSeed–Late Stage$100K – $1M
World Innovation Lab (WiL)
Palo AltoPre-Seed–Late Stage$5M – $30M
Yonghua Capital
ShanghaiSeed–Late Stage$142K – $100M
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
BrightEdge
AtlantaSeed–Late Stage
1 person
Hanne Capital
ShanghaiSeed–Late Stage
2 people
Launchpad Digital Health
EmeryvillePre-Seed–Late Stage
2 people
Advantech Capital
Camana BayGrowth–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Sk Capital (VEB.RF-backed)
MoscowSeed–Late Stage
1 person
Trustbridge Partners
ShanghaiSeries B–Late Stage
1 person
Walter Capital Partners
MontrealGrowth–Late Stage
1 person
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.
